Iran enters third trial phase of domestic coronavirus vaccine
Iran-made vaccines may be available this summer as cases continue to rise despite lockdown measures.
Iran is nearing completion of a domestically produced vaccine for the coronavirus, according to state-affiliated media. A nationwide vaccine campaign for the public could still be several weeks away, however, as cases continue to rise despite lockdown measures.
The COVIran Barekat vaccine entered its third trial phase on April 25. The current phase consists of a human trial involving more than 20,000 people in various cities, according to the semi-official Tasnim News Agency. Previous trial phases showed the vaccine to be successful, according to officials.
The joint Iranian-Cuban Pasteur vaccine’s third trial also began on April 26 in Isfahan province, the official Islamic Republic News Agency reported.
Iranian President Hassan Rouhani said Iranian-made vaccines will be available to the public in late spring or early summer, the semi-official Fars News Agency reported today.
